Visentin, A. and Trentin, L. (2022) “Comment on: ‘Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients’”, Haematologica. Pavia, Italy, 107(6), pp. 1489-1490. doi: 10.3324/haematol.2021.280199.